metformin

(redirected from Glucophage xr)
Also found in: Dictionary, Medical.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for metformin

an antidiabetic drug (trade name Glucophage) prescribed to treat type II diabetes

References in periodicals archive ?
The NewMet 1000 milligram dose was approximately 50% more effective than 1000 milligrams of Glucophage XR and approximately 70% as effective as 2000 milligrams of Glucophage XR.
Pharmaceutical company Merck Serono said in a statement that Glucophage XR is an advanced formulation of the oral anti-diabetic agent Metformin.
Bristol-Myers Squibb Company has two of the highest ranked products, Glucophage XR and Abilify, with Abilify co-promoted through Otsuka America Pharmaceuticals Inc.
Metformin hydrochloride ER tablets USP 500mg and 750mg, which is ready for launch, is the generic equivalent of Bristol Myers Squibb Company (BMS) s Glucophage XR extended-release tablets 500mg and 750mg respectively.
Nasdaq:DEPO) reported results from an in vitro dissolution study that demonstrated statistically significantly different release rates between generic metformin extended release products compared to the currently marketed branded product, Glucophage XR.
However, the revenue growth of oral anti-diabetic agents continues to slow (+5% YoY) due to the patent expiry of leading brands such as Glucophage, Glucophage XR and Glucovance and a slow down in prescription demand.
0 include the following: Abilify, Actonel, Advair, Aranesp, Aricept, Avandia, Boniva, Botox, Caduet, Concerta, Crestor, Cymbalta, Depakote, Depo- Provera, Detrol LA, Effexor XR, Enbrel, Flomax, Flonase, Flovent, Fosamax, Gardasil, Glucophage XR, Humira, Humulin, Imitrex, Lantus, Lexapro, Lipitor, Nasacort, Nasonex, Neulasta, Neurontin, Nexium, Norvasc, NuvaRing, Ortho Tri- Cyclen Lo, Paxil, Plavix, Pravachol, Prevacid, Protonix, Provigil, Pulmicort, Restasis, Risperdal, Rozerem, Seasonale, Seroquel, Singulair, Strattera, Tamiflu, Topamax, Toprol XL, Tricor, Valtrex, Vytorin, Yasmin, Yaz, Zocor, Zoloft, Zomig, Zyprexa and Zyrtec.
Bristol Meyers Squibb Company (NYSE:BMY) markets Glucophage XR as an antidiabetic drug for the treatment of Type 2 (non-insulin dependent) diabetes.
Lubbert played an integral role in the success of the billion dollar diabetes franchise that included Glucophage, Glucovance and Glucophage XR.
During that time, he directed the regulatory activities for a number of medically important programs, including Pravachol, Monopril, Avapro, Glucovance, and Glucophage XR.
market sales of Glucophage XR 500mg and the other marketed generic and authorized generic versions were approximately $430 million in the twelve months ended March 31, 2004.
Metformin HCl Extended-Release Tablets, 500 mg are the AB-rated generic equivalent of Bristol-Myers Squibb's Glucophage XR Tablets, 500 mg, a treatment for type 2 diabetes.
Barr filed an Abbreviated New Drug Application (ANDA) for metformin hydrochloride extended-release tablets, 750 mg that contained a challenge to the patent listed in the Orange Book for Glucophage XR.
In 2002, sales of the extended release metformin product Glucophage XR accounted for approximately 38% of the $778 million Glucophage franchise, growing to 43% by the end of Q3 2003.